Skip to main content


Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes

Fig. 1

Kaplan-Meier curves for time to readmission within one year for patients receiving sulfonylurea monotherapy versus monotherapy with another oral antihyperglycemic agent. Each data point along the two curves represents the proportion of patients not readmitted to the hospital after a specified length of time following their first diabetes-related hospitalization. At the end of one year, approximately 72 % of patients taking a sulfonylurea remained out of the hospital, whereas over 80 % of patients not taking a sulfonylurea had not been rehospitalized

Back to article page